Skip to main content
Top

Clinical & Experimental Metastasis

Issue 2/2008

Content (9 Articles)

Research Paper

Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer

Sunny Y. Wong, Denise Crowley, Roderick T. Bronson, Richard O. Hynes

Research Paper

Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis

Jude R. Canon, Martine Roudier, Rebecca Bryant, Sean Morony, Marina Stolina, Paul J. Kostenuik, William C. Dougall

Research Paper

Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth

William G. McDermott, Mathieu Boissan, Marie-Lise Lacombe, Patricia S. Steeg, Christine E. Horak

Research Paper

CNTO 95, a fully human anti αv integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells

Qiming Chen, Carol D. Manning, Hillary Millar, Francis L. McCabe, Catherine Ferrante, Celia Sharp, Lillian Shahied-Arruda, Parul Doshi, Marian T. Nakada, G. Mark Anderson

Review

Histone deacetylases: target enzymes for cancer therapy

Denis Mottet, Vincent Castronovo

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine